Nanotecnoloxías aplicadas ao deseño de sistemas de liberación de fármacos
NANOBIOFAR
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (6)
2024
-
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Vaccines, Vol. 12, Núm. 1
-
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)
npj Vaccines
-
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Emerging Microbes and Infections, Vol. 13, Núm. 1
-
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines, Vol. 9, Núm. 1
2023
2019
-
Intracellular delivery of an antibody targeting gasdermin-b reduces her2 breast cancer aggressiveness
Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4846-4858